Copyright Reports & Markets. All rights reserved.

Global Drugs Based on Gene Therapy Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Drugs Based on Gene Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Based on Viral
    • 1.2.3 Based on Non-viral
  • 1.3 Market by Application
    • 1.3.1 Global Drugs Based on Gene Therapy Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Neurological Diseases
    • 1.3.3 Cancer
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Drugs Based on Gene Therapy Market Perspective (2016-2027)
  • 2.2 Drugs Based on Gene Therapy Growth Trends by Regions
    • 2.2.1 Drugs Based on Gene Therapy Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Drugs Based on Gene Therapy Historic Market Share by Regions (2016-2021)
    • 2.2.3 Drugs Based on Gene Therapy Forecasted Market Size by Regions (2022-2027)
  • 2.3 Drugs Based on Gene Therapy Industry Dynamic
    • 2.3.1 Drugs Based on Gene Therapy Market Trends
    • 2.3.2 Drugs Based on Gene Therapy Market Drivers
    • 2.3.3 Drugs Based on Gene Therapy Market Challenges
    • 2.3.4 Drugs Based on Gene Therapy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Drugs Based on Gene Therapy Players by Revenue
    • 3.1.1 Global Top Drugs Based on Gene Therapy Players by Revenue (2016-2021)
    • 3.1.2 Global Drugs Based on Gene Therapy Revenue Market Share by Players (2016-2021)
  • 3.2 Global Drugs Based on Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Drugs Based on Gene Therapy Revenue
  • 3.4 Global Drugs Based on Gene Therapy Market Concentration Ratio
    • 3.4.1 Global Drugs Based on Gene Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Drugs Based on Gene Therapy Revenue in 2020
  • 3.5 Drugs Based on Gene Therapy Key Players Head office and Area Served
  • 3.6 Key Players Drugs Based on Gene Therapy Product Solution and Service
  • 3.7 Date of Enter into Drugs Based on Gene Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs Based on Gene Therapy Breakdown Data by Type

  • 4.1 Global Drugs Based on Gene Therapy Historic Market Size by Type (2016-2021)
  • 4.2 Global Drugs Based on Gene Therapy Forecasted Market Size by Type (2022-2027)

5 Drugs Based on Gene Therapy Breakdown Data by Application

  • 5.1 Global Drugs Based on Gene Therapy Historic Market Size by Application (2016-2021)
  • 5.2 Global Drugs Based on Gene Therapy Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Drugs Based on Gene Therapy Market Size (2016-2027)
  • 6.2 North America Drugs Based on Gene Therapy Market Size by Type
    • 6.2.1 North America Drugs Based on Gene Therapy Market Size by Type (2016-2021)
    • 6.2.2 North America Drugs Based on Gene Therapy Market Size by Type (2022-2027)
    • 6.2.3 North America Drugs Based on Gene Therapy Market Size by Type (2016-2027)
  • 6.3 North America Drugs Based on Gene Therapy Market Size by Application
    • 6.3.1 North America Drugs Based on Gene Therapy Market Size by Application (2016-2021)
    • 6.3.2 North America Drugs Based on Gene Therapy Market Size by Application (2022-2027)
    • 6.3.3 North America Drugs Based on Gene Therapy Market Size by Application (2016-2027)
  • 6.4 North America Drugs Based on Gene Therapy Market Size by Country
    • 6.4.1 North America Drugs Based on Gene Therapy Market Size by Country (2016-2021)
    • 6.4.2 North America Drugs Based on Gene Therapy Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Drugs Based on Gene Therapy Market Size (2016-2027)
  • 7.2 Europe Drugs Based on Gene Therapy Market Size by Type
    • 7.2.1 Europe Drugs Based on Gene Therapy Market Size by Type (2016-2021)
    • 7.2.2 Europe Drugs Based on Gene Therapy Market Size by Type (2022-2027)
    • 7.2.3 Europe Drugs Based on Gene Therapy Market Size by Type (2016-2027)
  • 7.3 Europe Drugs Based on Gene Therapy Market Size by Application
    • 7.3.1 Europe Drugs Based on Gene Therapy Market Size by Application (2016-2021)
    • 7.3.2 Europe Drugs Based on Gene Therapy Market Size by Application (2022-2027)
    • 7.3.3 Europe Drugs Based on Gene Therapy Market Size by Application (2016-2027)
  • 7.4 Europe Drugs Based on Gene Therapy Market Size by Country
    • 7.4.1 Europe Drugs Based on Gene Therapy Market Size by Country (2016-2021)
    • 7.4.2 Europe Drugs Based on Gene Therapy Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Drugs Based on Gene Therapy Market Size (2016-2027)
  • 8.2 Asia-Pacific Drugs Based on Gene Therapy Market Size by Type
    • 8.2.1 Asia-Pacific Drugs Based on Gene Therapy Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Drugs Based on Gene Therapy Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Drugs Based on Gene Therapy Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Drugs Based on Gene Therapy Market Size by Application
    • 8.3.1 Asia-Pacific Drugs Based on Gene Therapy Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Drugs Based on Gene Therapy Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Drugs Based on Gene Therapy Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Drugs Based on Gene Therapy Market Size by Region
    • 8.4.1 Asia-Pacific Drugs Based on Gene Therapy Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Drugs Based on Gene Therapy Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Drugs Based on Gene Therapy Market Size (2016-2027)
  • 9.2 Latin America Drugs Based on Gene Therapy Market Size by Type
    • 9.2.1 Latin America Drugs Based on Gene Therapy Market Size by Type (2016-2021)
    • 9.2.2 Latin America Drugs Based on Gene Therapy Market Size by Type (2022-2027)
    • 9.2.3 Latin America Drugs Based on Gene Therapy Market Size by Type (2016-2027)
  • 9.3 Latin America Drugs Based on Gene Therapy Market Size by Application
    • 9.3.1 Latin America Drugs Based on Gene Therapy Market Size by Application (2016-2021)
    • 9.3.2 Latin America Drugs Based on Gene Therapy Market Size by Application (2022-2027)
    • 9.3.3 Latin America Drugs Based on Gene Therapy Market Size by Application (2016-2027)
  • 9.4 Latin America Drugs Based on Gene Therapy Market Size by Country
    • 9.4.1 Latin America Drugs Based on Gene Therapy Market Size by Country (2016-2021)
    • 9.4.2 Latin America Drugs Based on Gene Therapy Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Drugs Based on Gene Therapy Market Size (2016-2027)
  • 10.2 Middle East & Africa Drugs Based on Gene Therapy Market Size by Type
    • 10.2.1 Middle East & Africa Drugs Based on Gene Therapy Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Drugs Based on Gene Therapy Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Drugs Based on Gene Therapy Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Drugs Based on Gene Therapy Market Size by Application
    • 10.3.1 Middle East & Africa Drugs Based on Gene Therapy Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Drugs Based on Gene Therapy Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Drugs Based on Gene Therapy Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Drugs Based on Gene Therapy Market Size by Country
    • 10.4.1 Middle East & Africa Drugs Based on Gene Therapy Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Drugs Based on Gene Therapy Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Biogen
    • 11.1.1 Biogen Company Details
    • 11.1.2 Biogen Business Overview
    • 11.1.3 Biogen Drugs Based on Gene Therapy Introduction
    • 11.1.4 Biogen Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.1.5 Biogen Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Drugs Based on Gene Therapy Introduction
    • 11.2.4 Novartis Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.2.5 Novartis Recent Development
  • 11.3 Gilead Sciences
    • 11.3.1 Gilead Sciences Company Details
    • 11.3.2 Gilead Sciences Business Overview
    • 11.3.3 Gilead Sciences Drugs Based on Gene Therapy Introduction
    • 11.3.4 Gilead Sciences Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.3.5 Gilead Sciences Recent Development
  • 11.4 Sarepta Therapeutics
    • 11.4.1 Sarepta Therapeutics Company Details
    • 11.4.2 Sarepta Therapeutics Business Overview
    • 11.4.3 Sarepta Therapeutics Drugs Based on Gene Therapy Introduction
    • 11.4.4 Sarepta Therapeutics Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.4.5 Sarepta Therapeutics Recent Development
  • 11.5 Alnylam Pharmaceuticals
    • 11.5.1 Alnylam Pharmaceuticals Company Details
    • 11.5.2 Alnylam Pharmaceuticals Business Overview
    • 11.5.3 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Introduction
    • 11.5.4 Alnylam Pharmaceuticals Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.5.5 Alnylam Pharmaceuticals Recent Development
  • 11.6 Amgen
    • 11.6.1 Amgen Company Details
    • 11.6.2 Amgen Business Overview
    • 11.6.3 Amgen Drugs Based on Gene Therapy Introduction
    • 11.6.4 Amgen Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.6.5 Amgen Recent Development
  • 11.7 Spark Therapeutics
    • 11.7.1 Spark Therapeutics Company Details
    • 11.7.2 Spark Therapeutics Business Overview
    • 11.7.3 Spark Therapeutics Drugs Based on Gene Therapy Introduction
    • 11.7.4 Spark Therapeutics Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.7.5 Spark Therapeutics Recent Development
  • 11.8 Akcea Therapeutics
    • 11.8.1 Akcea Therapeutics Company Details
    • 11.8.2 Akcea Therapeutics Business Overview
    • 11.8.3 Akcea Therapeutics Drugs Based on Gene Therapy Introduction
    • 11.8.4 Akcea Therapeutics Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.8.5 Akcea Therapeutics Recent Development
  • 11.9 Bluebird bio
    • 11.9.1 Bluebird bio Company Details
    • 11.9.2 Bluebird bio Business Overview
    • 11.9.3 Bluebird bio Drugs Based on Gene Therapy Introduction
    • 11.9.4 Bluebird bio Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.9.5 Bluebird bio Recent Development
  • 11.10 Sunway Biotech
    • 11.10.1 Sunway Biotech Company Details
    • 11.10.2 Sunway Biotech Business Overview
    • 11.10.3 Sunway Biotech Drugs Based on Gene Therapy Introduction
    • 11.10.4 Sunway Biotech Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.10.5 Sunway Biotech Recent Development
  • 11.11 SIBIONO
    • 11.11.1 SIBIONO Company Details
    • 11.11.2 SIBIONO Business Overview
    • 11.11.3 SIBIONO Drugs Based on Gene Therapy Introduction
    • 11.11.4 SIBIONO Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.11.5 SIBIONO Recent Development
  • 11.12 AnGes
    • 11.12.1 AnGes Company Details
    • 11.12.2 AnGes Business Overview
    • 11.12.3 AnGes Drugs Based on Gene Therapy Introduction
    • 11.12.4 AnGes Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.12.5 AnGes Recent Development
  • 11.13 Orchard Therapeutics
    • 11.13.1 Orchard Therapeutics Company Details
    • 11.13.2 Orchard Therapeutics Business Overview
    • 11.13.3 Orchard Therapeutics Drugs Based on Gene Therapy Introduction
    • 11.13.4 Orchard Therapeutics Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.13.5 Orchard Therapeutics Recent Development
  • 11.14 Human Stem Cells Institute
    • 11.14.1 Human Stem Cells Institute Company Details
    • 11.14.2 Human Stem Cells Institute Business Overview
    • 11.14.3 Human Stem Cells Institute Drugs Based on Gene Therapy Introduction
    • 11.14.4 Human Stem Cells Institute Revenue in Drugs Based on Gene Therapy Business (2016-2021)
    • 11.14.5 Human Stem Cells Institute Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Drugs Based on Gene Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drugs Based on Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Based on Viral
    Based on Non-viral

    Segment by Application
    Neurological Diseases
    Cancer
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    Bluebird bio
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    AnGes
    Orchard Therapeutics

    Buy now